KR102364945B1 - 건조 분말 흡입기 - Google Patents

건조 분말 흡입기 Download PDF

Info

Publication number
KR102364945B1
KR102364945B1 KR1020167011976A KR20167011976A KR102364945B1 KR 102364945 B1 KR102364945 B1 KR 102364945B1 KR 1020167011976 A KR1020167011976 A KR 1020167011976A KR 20167011976 A KR20167011976 A KR 20167011976A KR 102364945 B1 KR102364945 B1 KR 102364945B1
Authority
KR
South Korea
Prior art keywords
dry powder
dose
inhaler
port
salmeterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167011976A
Other languages
English (en)
Korean (ko)
Other versions
KR20160065204A (ko
Inventor
무쿨 달비
세아 키 티
Original Assignee
테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51743574&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102364945(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 filed Critical 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드
Publication of KR20160065204A publication Critical patent/KR20160065204A/ko
Application granted granted Critical
Publication of KR102364945B1 publication Critical patent/KR102364945B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/0006—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
    • A61M15/0008—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means rotating by airflow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007—Mechanical counters
    • A61M15/0071—Mechanical counters having a display or indicator
    • A61M15/0076—Mechanical counters having a display or indicator on a drum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007—Mechanical counters
    • A61M15/0071—Mechanical counters having a display or indicator
    • A61M15/0078—Mechanical counters having a display or indicator on a strip
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020167011976A 2013-10-07 2014-10-06 건조 분말 흡입기 Active KR102364945B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361887589P 2013-10-07 2013-10-07
US61/887,589 2013-10-07
US201361888301P 2013-10-08 2013-10-08
US61/888,301 2013-10-08
PCT/US2014/059285 WO2015054124A2 (en) 2013-10-07 2014-10-06 Dry powder inhaler

Publications (2)

Publication Number Publication Date
KR20160065204A KR20160065204A (ko) 2016-06-08
KR102364945B1 true KR102364945B1 (ko) 2022-02-17

Family

ID=51743574

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167011976A Active KR102364945B1 (ko) 2013-10-07 2014-10-06 건조 분말 흡입기

Country Status (23)

Country Link
US (2) US20160243320A1 (https=)
EP (1) EP3054920B1 (https=)
JP (1) JP6543620B2 (https=)
KR (1) KR102364945B1 (https=)
CN (1) CN105636630B (https=)
AU (1) AU2014332191B2 (https=)
BR (1) BR112016007771B1 (https=)
CA (1) CA2926432A1 (https=)
CL (1) CL2016000735A1 (https=)
DK (1) DK3054920T3 (https=)
EA (1) EA035329B1 (https=)
ES (1) ES2863198T3 (https=)
HK (1) HK1222127A1 (https=)
HU (1) HUE055042T2 (https=)
IL (1) IL244959B (https=)
MX (1) MX374870B (https=)
PE (1) PE20160543A1 (https=)
PH (1) PH12016500619A1 (https=)
PL (1) PL3054920T3 (https=)
PT (1) PT3054920T (https=)
TW (1) TWI673070B (https=)
WO (1) WO2015054124A2 (https=)
ZA (1) ZA201601960B (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9446209B2 (en) 2011-09-07 2016-09-20 Concentrx Pharmaceuticals, Inc. Dry powder inhalation device
MX374870B (es) * 2013-10-07 2025-03-06 Teva Branded Pharmaceutical Products R&D Inc Inhalador de polvo seco.
AU356105S (en) * 2013-11-29 2014-06-24 Norton Waterford Ltd Respiratory apparatus
USD769436S1 (en) * 2013-11-29 2016-10-18 Norton (Waterford) Limited Respiratory apparatus
USD752734S1 (en) 2014-03-10 2016-03-29 Civitas Therapeutics, Inc. Inhaler grip
USD755367S1 (en) * 2014-03-10 2016-05-03 Civitas Therapeutics, Inc. Indicator for an inhaler
USD752204S1 (en) * 2014-03-10 2016-03-22 Civitas Therapeutics, Inc. Indicator for an inhaler
MA41378A (fr) * 2015-01-20 2017-11-28 Teva Branded Pharmaceutical Prod R & D Inc Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol
CN107095875B (zh) * 2016-02-23 2022-03-18 天津金耀集团有限公司 一种昔奈酸沙美特罗丙酸氟替卡松复方粉吸入剂组合物
JP7231410B2 (ja) * 2016-04-12 2023-03-01 バイオコープ プロダクション エス．アー． 定量吸入器用アドオン装置、遵守向上システム、及び定量吸入器における使用の遵守向上のための方法
CN106267484A (zh) * 2016-08-08 2017-01-04 中山市美捷时包装制品有限公司 一种干粉吸入装置的定量供料机构
USD832998S1 (en) * 2016-10-21 2018-11-06 Norton (Waterford) Limited Inhaler
USD852947S1 (en) * 2016-10-21 2019-07-02 Norton (Waterford) Limited Inhaler
USD832997S1 (en) * 2016-10-21 2018-11-06 Norton (Waterford) Limited Inhaler
US11344685B2 (en) 2016-11-18 2022-05-31 Norton (Waterford) Limited Drug delivery device with electronics
USD853555S1 (en) * 2017-01-03 2019-07-09 Norton (Waterford) Limited Inhaler
GB201700727D0 (en) * 2017-01-16 2017-03-01 Teva Pharma Inhalers and airflow adaptors therefor
AU2018244582A1 (en) 2017-03-28 2019-09-19 Concentrx Pharmaceuticals, Inc. Devices and methods for delivering dry powder medicaments
CN107715264B (zh) * 2017-10-12 2021-01-29 上海新黄河制药有限公司 一种粉雾剂装置制剂粉末团聚物的分散/解聚装置
CN107737393B (zh) * 2017-10-12 2020-08-28 上海新黄河制药有限公司 一种用于粉雾剂吸入装置的制剂雾化流道
CN111542308B (zh) 2017-12-13 2024-04-02 埃姆弗西斯进出口及分销有限公司 干粉吸入器
USD948703S1 (en) * 2019-07-26 2022-04-12 Lupin Ltd. Inhaler
USD948704S1 (en) * 2019-07-26 2022-04-12 Lupin Ltd. Inhaler
USD949323S1 (en) * 2019-07-26 2022-04-19 Lupin Ltd. Inhaler
USD949324S1 (en) * 2019-07-26 2022-04-19 Lupin Ltd. Inhaler
USD1006214S1 (en) * 2020-02-14 2023-11-28 Aptar France Sas Inhaler
USD1006213S1 (en) * 2020-02-14 2023-11-28 Aptar France Sas Inhaler
WO2021219535A1 (en) * 2020-04-27 2021-11-04 Jt International Sa Aerosol generation device
MX2023001875A (es) 2020-08-14 2023-06-29 Norton Waterford Ltd Formulación inhalable de propionato de fluticasona y sulfato de albuterol.
GB202012742D0 (en) * 2020-08-14 2020-09-30 Norton Waterford Ltd An inhalable medicament
KR102767525B1 (ko) 2022-01-24 2025-02-14 주식회사 케이티앤지 흡입기
KR102782140B1 (ko) 2022-08-25 2025-03-18 주식회사 케이티앤지 흡입기
KR102864455B1 (ko) 2022-09-14 2025-09-26 주식회사 케이티앤지 흡입기
KR102783650B1 (ko) 2022-09-14 2025-03-19 주식회사 케이티앤지 흡입기
KR102885446B1 (ko) 2022-09-19 2025-11-14 주식회사 케이티앤지 흡입기
KR102917969B1 (ko) 2022-12-30 2026-01-26 주식회사 케이티앤지 흡입기
CN121816176A (zh) 2023-07-07 2026-04-07 诺顿（沃特福特）有限公司 一种用于治疗哮喘的丙酸氟替卡松和硫酸沙丁胺醇的吸入制剂
WO2025012114A1 (en) 2023-07-07 2025-01-16 Norton (Waterford) Limited An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma
EP4487837A1 (en) 2023-07-07 2025-01-08 Norton (Waterford) Limited An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma
WO2025199032A1 (en) * 2024-03-18 2025-09-25 Transpire Bio Inc. Trigger mechanism and powder inhalation device
WO2026013023A1 (en) 2024-07-08 2026-01-15 Norton (Waterford) Limited A fixed-dose dry powder inhalation formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma
EP4678170A1 (en) 2024-07-08 2026-01-14 Norton (Waterford) Limited A fixed-dose dry powder inhalation formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100518721B1 (ko) * 2000-06-23 2005-10-05 노턴 헬스케어 리미티드 약제 흡입기
WO2011145109A1 (en) * 2010-05-20 2011-11-24 Sun Pharma Advanced Research Company Ltd., Dry powder inhalation composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
TWI224511B (en) 2000-06-23 2004-12-01 Norton Healthcare Ltd De-agglomerator for breath-actuated dry powder inhaler
GB0124523D0 (en) * 2001-10-12 2001-12-05 Glaxo Group Ltd Pharmaceutical combination
DE60239639D1 (de) * 2002-07-31 2011-05-12 Chiesi Farma Spa Pulverinhalator
US20040105821A1 (en) * 2002-09-30 2004-06-03 Howard Bernstein Sustained release pharmaceutical formulation for inhalation
JP5356367B2 (ja) * 2007-04-30 2013-12-04 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド 吸入装置
JP2008301847A (ja) * 2007-06-05 2008-12-18 Canon Inc 吸入装置及びその駆動方法
EP2197444A1 (en) * 2007-09-12 2010-06-23 Glaxo Group Limited Novel combination of therapeutic agents
PL3111927T3 (pl) * 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
GB0919465D0 (en) * 2009-11-06 2009-12-23 Norton Healthcare Ltd Airflow adaptor for a breath-actuated dry powder inhaler
MX374870B (es) * 2013-10-07 2025-03-06 Teva Branded Pharmaceutical Products R&D Inc Inhalador de polvo seco.
MA41378A (fr) * 2015-01-20 2017-11-28 Teva Branded Pharmaceutical Prod R & D Inc Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100518721B1 (ko) * 2000-06-23 2005-10-05 노턴 헬스케어 리미티드 약제 흡입기
WO2011145109A1 (en) * 2010-05-20 2011-11-24 Sun Pharma Advanced Research Company Ltd., Dry powder inhalation composition

Also Published As

Publication number Publication date
MX374870B (es) 2025-03-06
CN105636630A (zh) 2016-06-01
EP3054920A2 (en) 2016-08-17
JP6543620B2 (ja) 2019-07-10
BR112016007771B1 (pt) 2023-03-28
PH12016500619B1 (en) 2016-06-13
AU2014332191A1 (en) 2016-04-21
TW201542252A (zh) 2015-11-16
CN105636630B (zh) 2020-05-19
EA035329B1 (ru) 2020-05-28
EA201690738A1 (ru) 2016-08-31
TWI673070B (zh) 2019-10-01
PT3054920T (pt) 2021-03-23
MX2016004316A (es) 2016-10-12
WO2015054124A2 (en) 2015-04-16
PL3054920T3 (pl) 2021-07-05
BR112016007771A2 (https=) 2017-08-01
IL244959B (en) 2020-11-30
ZA201601960B (en) 2017-08-30
KR20160065204A (ko) 2016-06-08
DK3054920T3 (da) 2021-03-29
CL2016000735A1 (es) 2016-11-11
ES2863198T3 (es) 2021-10-08
PH12016500619A1 (en) 2016-06-13
HUE055042T2 (hu) 2021-10-28
CA2926432A1 (en) 2015-04-16
US9066957B2 (en) 2015-06-30
PE20160543A1 (es) 2016-06-05
HK1222127A1 (zh) 2017-06-23
JP2016536043A (ja) 2016-11-24
AU2014332191B2 (en) 2020-04-02
NZ718315A (en) 2021-10-29
IL244959A0 (en) 2016-05-31
WO2015054124A3 (en) 2015-09-03
US20160243320A1 (en) 2016-08-25
EP3054920B1 (en) 2021-03-03
HK1219444A1 (zh) 2017-04-07
US20150099726A1 (en) 2015-04-09

Similar Documents

Publication Publication Date Title
KR102364945B1 (ko) 건조 분말 흡입기
AU2018226472B2 (en) Dry powder inhaler
AU2016209363B2 (en) Dry powder inhaler comprising fluticasone propionate and salmeterol xinafoat
AU2018204860A1 (en) Inhalable medicaments
NZ718315B2 (en) Dry powder inhaler
HK1219444B (zh) 干粉吸入器
HK1242605A1 (en) Dry powder inhaler comprising fluticasone propionate and salmeterol xinafoat
HK1262834A1 (en) Dry powder inhaler
HK1262834B (en) Dry powder inhaler

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160504

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20191004

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210420

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20211123

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220215

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220215

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20250210

Start annual number: 4

End annual number: 4